Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Antihypertensive medications and risk of death and hospitalizations in US hemodialysis patients: Evidence from a cohort study to inform hypertension treatment practices.

Shafi T, Sozio SM, Luly J, Bandeen-Roche KJ, St Peter WL, Ephraim PL, McDermott A, Herzog CA, Crews DC, Scialla JJ, Tangri N, Miskulin DC, Michels WM, Jaar BG, Zager PG, Meyer KB, Wu AW, Boulware LE; DEcIDE Network Patient Outcomes in End Stage Renal Disease Study Investigators.

Medicine (Baltimore). 2017 Feb;96(5):e5924. doi: 10.1097/MD.0000000000005924.

2.

Comparison of Prescribed and Measured Dialysate Sodium: A Quality Improvement Project.

Gul A, Miskulin DC, Paine SS, Narsipur SS, Arbeit LA, Harford AM, Weiner DE, Schrader R, Horowitz BL, Zager PG.

Am J Kidney Dis. 2016 Mar;67(3):439-45. doi: 10.1053/j.ajkd.2015.11.004. Epub 2016 Jan 6.

PMID:
26776538
3.

Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).

Iyengar SK, Sedor JR, Freedman BI, Kao WH, Kretzler M, Keller BJ, Abboud HE, Adler SG, Best LG, Bowden DW, Burlock A, Chen YD, Cole SA, Comeau ME, Curtis JM, Divers J, Drechsler C, Duggirala R, Elston RC, Guo X, Huang H, Hoffmann MM, Howard BV, Ipp E, Kimmel PL, Klag MJ, Knowler WC, Kohn OF, Leak TS, Leehey DJ, Li M, Malhotra A, März W, Nair V, Nelson RG, Nicholas SB, O'Brien SJ, Pahl MV, Parekh RS, Pezzolesi MG, Rasooly RS, Rotimi CN, Rotter JI, Schelling JR, Seldin MF, Shah VO, Smiles AM, Smith MW, Taylor KD, Thameem F, Thornley-Brown DP, Truitt BJ, Wanner C, Weil EJ, Winkler CA, Zager PG, Igo RP Jr, Hanson RL, Langefeld CD; Family Investigation of Nephropathy and Diabetes (FIND).

PLoS Genet. 2015 Aug 25;11(8):e1005352. doi: 10.1371/journal.pgen.1005352. eCollection 2015 Aug.

4.

Satisfaction with Care of Patients on Hemodialysis.

Richardson MM, Paine SS, Grobert ME, Stidley CA, Gabbay E, Harford AM, Zager PG, Miskulin DC, Meyer KB.

Clin J Am Soc Nephrol. 2015 Aug 7;10(8):1428-34. doi: 10.2215/CJN.11241114. Epub 2015 Jun 30.

5.

Genetics of kidney disease and related cardiometabolic phenotypes in Zuni Indians: the Zuni Kidney Project.

Laston SL, Voruganti VS, Haack K, Shah VO, Bobelu A, Bobelu J, Ghahate D, Harford AM, Paine SS, Tentori F, Cole SA, MacCluer JW, Comuzzie AG, Zager PG.

Front Genet. 2015 Jan 30;6:6. doi: 10.3389/fgene.2015.00006. eCollection 2015.

6.

Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy.

Kalantar-Zadeh K, Unruh M, Zager PG, Kovesdy CP, Bargman JM, Chen J, Sankarasubbaiyan S, Shah G, Golper T, Sherman RA, Goldfarb DS.

Am J Kidney Dis. 2014 Aug;64(2):181-6. doi: 10.1053/j.ajkd.2014.04.019. Epub 2014 May 17. Review.

7.

Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study.

Shafi T, Zager PG, Sozio SM, Grams ME, Jaar BG, Christenson RH, Boulware LE, Parekh RS, Powe NR, Coresh J.

Am J Kidney Dis. 2014 Sep;64(3):443-51. doi: 10.1053/j.ajkd.2014.03.015. Epub 2014 Apr 29.

8.

Hypertension in hemodialysis patients: an opinion-based update.

Shafi T, Waheed S, Zager PG.

Semin Dial. 2014 Mar;27(2):146-53. doi: 10.1111/sdi.12195. Epub 2014 Feb 5. Review.

9.

Relationships of clinic size, geographic region, and race/ethnicity to the frequency of missed/shortened dialysis treatments.

Obialo C, Zager PG, Myers OB, Hunt WC.

J Nephrol. 2014 Aug;27(4):425-30. doi: 10.1007/s40620-013-0035-y. Epub 2014 Jan 21.

PMID:
24446347
10.

Predialysis systolic BP variability and outcomes in hemodialysis patients.

Shafi T, Sozio SM, Bandeen-Roche KJ, Ephraim PL, Luly JR, St Peter WL, McDermott A, Scialla JJ, Crews DC, Tangri N, Miskulin DC, Michels WM, Jaar BG, Herzog CA, Zager PG, Meyer KB, Wu AW, Boulware LE; DEcIDE Network Patient Outcomes in End Stage Renal Disease Study Investigators.

J Am Soc Nephrol. 2014 Apr;25(4):799-809. doi: 10.1681/ASN.2013060667. Epub 2014 Jan 2.

11.

A genome-wide search for linkage of estimated glomerular filtration rate (eGFR) in the Family Investigation of Nephropathy and Diabetes (FIND).

Thameem F, Igo RP Jr, Freedman BI, Langefeld C, Hanson RL, Schelling JR, Elston RC, Duggirala R, Nicholas SB, Goddard KA, Divers J, Guo X, Ipp E, Kimmel PL, Meoni LA, Shah VO, Smith MW, Winkler CA, Zager PG, Knowler WC, Nelson RG, Pahl MV, Parekh RS, Kao WH, Rasooly RS, Adler SG, Abboud HE, Iyengar SK, Sedor JR; Family Investigation of Nephropathy and Diabetes Research Group.

PLoS One. 2013 Dec 17;8(12):e81888. doi: 10.1371/journal.pone.0081888. eCollection 2013.

12.

Oral intradialytic nutritional supplement use and mortality in hemodialysis patients.

Weiner DE, Tighiouart H, Ladik V, Meyer KB, Zager PG, Johnson DS.

Am J Kidney Dis. 2014 Feb;63(2):276-85. doi: 10.1053/j.ajkd.2013.08.007. Epub 2013 Oct 3.

PMID:
24094606
13.

Relationship of missed and shortened hemodialysis treatments to hospitalization and mortality: observations from a US dialysis network.

Obialo CI, Hunt WC, Bashir K, Zager PG.

Clin Kidney J. 2012 Aug;5(4):315-9. doi: 10.1093/ckj/sfs071.

14.

Heritability of serum sodium concentration: evidence for sex- and ethnic-specific effects.

Wilmot B, Voruganti VS, Chang YP, Fu Y, Chen Z, Taylor HA, Wilson JG, Gipson T, Shah VO, Umans JG, Flessner MF, Hitzemann R, Shuldiner AR, Comuzzie AG, McWeeney S, Zager PG, Maccluer JW, Cole SA, Cohen DM.

Physiol Genomics. 2012 Feb 13;44(3):220-8. doi: 10.1152/physiolgenomics.00153.2011. Epub 2011 Dec 20.

15.

Genomewide linkage scan for diabetic renal failure and albuminuria: the FIND study.

Igo RP Jr, Iyengar SK, Nicholas SB, Goddard KA, Langefeld CD, Hanson RL, Duggirala R, Divers J, Abboud H, Adler SG, Arar NH, Horvath A, Elston RC, Bowden DW, Guo X, Ipp E, Kao WH, Kimmel PL, Knowler WC, Meoni LA, Molineros J, Nelson RG, Pahl MV, Parekh RS, Rasooly RS, Schelling JR, Shah VO, Smith MW, Winkler CA, Zager PG, Sedor JR, Freedman BI; Family Investigation of Nephropathy and Diabetes Research Group.

Am J Nephrol. 2011;33(5):381-9. doi: 10.1159/000326763. Epub 2011 Mar 31.

16.

Mortality risk in dialysis patients with naturally higher hemoglobins.

Harford AM, Zager PG.

J Am Soc Nephrol. 2011 Feb;22(2):205-6. doi: 10.1681/ASN.2010121281. No abstract available.

17.

Age, race, diabetes, blood pressure, and mortality among hemodialysis patients.

Myers OB, Adams C, Rohrscheib MR, Servilla KS, Miskulin D, Bedrick EJ, Zager PG.

J Am Soc Nephrol. 2010 Nov;21(11):1970-8. doi: 10.1681/ASN.2010010125. Epub 2010 Oct 14.

18.

Heritability of measures of kidney disease among Zuni Indians: the Zuni Kidney Project.

MacCluer JW, Scavini M, Shah VO, Cole SA, Laston SL, Voruganti VS, Paine SS, Eaton AJ, Comuzzie AG, Tentori F, Pathak DR, Bobelu A, Bobelu J, Ghahate D, Waikaniwa M, Zager PG.

Am J Kidney Dis. 2010 Aug;56(2):289-302. doi: 10.1053/j.ajkd.2010.03.012. Epub 2010 Jun 19.

19.

Increased CD36 expression signals monocyte activation among patients with type 2 diabetes.

Sun Y, Scavini M, Orlando RA, Murata GH, Servilla KS, Tzamaloukas AH, Schrader R, Bedrick EJ, Burge MR, Abumrad NA, Zager PG.

Diabetes Care. 2010 Sep;33(9):2065-7. doi: 10.2337/dc10-0460. Epub 2010 Jun 14.

20.

Left ventricular diastolic function in patients on hemodialysis.

Raizada V, Skipper B, Taylor RA, Luo W, Harford AA, Zager PG, Rohrscheib M, Spalding CT.

J Investig Med. 2010 Aug;58(6):791-5. doi: 10.231/JIM.0b013e3181e65ae2.

PMID:
20517163
21.

Hypertension in hemodialysis patients: the role of antihypertensive medications.

Miskulin DC, Zager PG.

Am J Kidney Dis. 2009 Dec;54(6):996-9. doi: 10.1053/j.ajkd.2009.08.002. Epub 2009 Oct 9. No abstract available.

PMID:
19819056
22.

Genome-wide linkage scans for type 2 diabetes mellitus in four ethnically diverse populations-significant evidence for linkage on chromosome 4q in African Americans: the Family Investigation of Nephropathy and Diabetes Research Group.

Malhotra A, Igo RP Jr, Thameem F, Kao WH, Abboud HE, Adler SG, Arar NH, Bowden DW, Duggirala R, Freedman BI, Goddard KA, Ipp E, Iyengar SK, Kimmel PL, Knowler WC, Kohn O, Leehey D, Meoni LA, Nelson RG, Nicholas SB, Parekh RS, Rich SS, Chen YD, Saad MF, Scavini M, Schelling JR, Sedor JR, Shah VO, Taylor KD, Thornley-Brown D, Zager PG, Horvath A, Hanson RL; Family Investigation of Nephropathy and Diabetes Research Group.

Diabetes Metab Res Rev. 2009 Nov;25(8):740-7. doi: 10.1002/dmrr.1031.

23.

Computerized decision support for EPO dosing in hemodialysis patients.

Miskulin DC, Weiner DE, Tighiouart H, Ladik V, Servilla K, Zager PG, Martin A, Johnson HK, Meyer KB; Medical Directors of Dialysis Clinic Inc.

Am J Kidney Dis. 2009 Dec;54(6):1081-8. doi: 10.1053/j.ajkd.2009.07.010. Epub 2009 Sep 25.

24.

Anemia management and association of race with mortality and hospitalization in a large not-for-profit dialysis organization.

Servilla KS, Singh AK, Hunt WC, Harford AM, Miskulin D, Meyer KB, Bedrick EJ, Rohrscheib MR, Tzamaloukas AH, Johnson HK, Zager PG.

Am J Kidney Dis. 2009 Sep;54(3):498-510. doi: 10.1053/j.ajkd.2009.05.007. Epub 2009 Jul 23.

PMID:
19628315
25.

Blood pressure and mortality risk in patients treated by peritoneal dialysis.

Zager PG, Rohrscheib MR.

Am J Kidney Dis. 2009 Jan;53(1):9-11. doi: 10.1053/j.ajkd.2008.10.036. No abstract available.

PMID:
19101397
26.

Heritability of the severity of diabetic retinopathy: the FIND-Eye study.

Arar NH, Freedman BI, Adler SG, Iyengar SK, Chew EY, Davis MD, Satko SG, Bowden DW, Duggirala R, Elston RC, Guo X, Hanson RL, Igo RP Jr, Ipp E, Kimmel PL, Knowler WC, Molineros J, Nelson RG, Pahl MV, Quade SR, Rasooly RS, Rotter JI, Saad MF, Scavini M, Schelling JR, Sedor JR, Shah VO, Zager PG, Abboud HE; Family Investigation of Nephropathy and Diabetes Research Group.

Invest Ophthalmol Vis Sci. 2008 Sep;49(9):3839-45. doi: 10.1167/iovs.07-1633.

27.

Age-related blood pressure patterns and blood pressure variability among hemodialysis patients.

Rohrscheib MR, Myers OB, Servilla KS, Adams CD, Miskulin D, Bedrick EJ, Hunt WC, Lindsey DE, Gabaldon D, Zager PG; DCI Medical Directors.

Clin J Am Soc Nephrol. 2008 Sep;3(5):1407-14. doi: 10.2215/CJN.00110108. Epub 2008 Aug 13.

28.

Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations: the Family Investigation of Nephropathy and Diabetes (FIND).

Schelling JR, Abboud HE, Nicholas SB, Pahl MV, Sedor JR, Adler SG, Arar NH, Bowden DW, Elston RC, Freedman BI, Goddard KA, Guo X, Hanson RL, Ipp E, Iyengar SK, Jun G, Kao WH, Kasinath BS, Kimmel PL, Klag MJ, Knowler WC, Nelson RG, Parekh RS, Quade SR, Rich SS, Saad MF, Scavini M, Smith MW, Taylor K, Winkler CA, Zager PG, Shah VO; Family Investigation of Nephropathy and Diabetes Research Group.

Diabetes. 2008 Jan;57(1):235-43. Epub 2007 Nov 14.

29.

Reducing versus discontinuing erythropoietin at high hemoglobin levels.

Weiner DE, Miskulin DC, Seefeld K, Ladik V, Zager PG, Singh AK, Johnson HK, Meyer KB.

J Am Soc Nephrol. 2007 Dec;18(12):3184-91. Epub 2007 Oct 31.

30.

The burden of chronic kidney disease among the Zuni Indians: the Zuni Kidney Project.

Scavini M, Stidley CA, Paine SS, Shah VO, Tentori F, Bobelu A, Welty TK, MacCluer JW, Zager PG.

Clin J Am Soc Nephrol. 2007 May;2(3):509-16. Epub 2007 Apr 18.

31.

Which targets in clinical practice guidelines are associated with improved survival in a large dialysis organization?

Tentori F, Hunt WC, Rohrscheib M, Zhu M, Stidley CA, Servilla K, Miskulin D, Meyer KB, Bedrick EJ, Johnson HK, Zager PG.

J Am Soc Nephrol. 2007 Aug;18(8):2377-84. Epub 2007 Jul 18.

32.

Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND).

Iyengar SK, Abboud HE, Goddard KA, Saad MF, Adler SG, Arar NH, Bowden DW, Duggirala R, Elston RC, Hanson RL, Ipp E, Kao WH, Kimmel PL, Klag MJ, Knowler WC, Meoni LA, Nelson RG, Nicholas SB, Pahl MV, Parekh RS, Quade SR, Rich SS, Rotter JI, Scavini M, Schelling JR, Sedor JR, Sehgal AR, Shah VO, Smith MW, Taylor KD, Winkler CA, Zager PG, Freedman BI; Family Investigation of Nephropathy and Diabetes Research Group.

Diabetes. 2007 Jun;56(6):1577-85. Epub 2007 Mar 15.

33.
34.
35.

Mortality risk among hemodialysis patients receiving different vitamin D analogs.

Tentori F, Hunt WC, Stidley CA, Rohrscheib MR, Bedrick EJ, Meyer KB, Johnson HK, Zager PG; Medical Directors of Dialysis Clinic Inc.

Kidney Int. 2006 Nov;70(10):1858-65. Epub 2006 Oct 4.

36.

Changing relationship of blood pressure with mortality over time among hemodialysis patients.

Stidley CA, Hunt WC, Tentori F, Schmidt D, Rohrscheib M, Paine S, Bedrick EJ, Meyer KB, Johnson HK, Zager PG; Medical Directors of Dialysis Clinic Inc.

J Am Soc Nephrol. 2006 Feb;17(2):513-20. Epub 2006 Jan 5.

37.

Renin-angiotensin polymorphisms and QTc interval prolongation in end-stage renal disease.

Raizada V, Skipper B, Luo W, Garza L, Hines CW, Harford AA, Zager PG, Griffith J, Raj D, Spalding CT.

Kidney Int. 2005 Sep;68(3):1186-9.

38.

Kidney disease among the Zuni Indians: the Zuni Kidney Project.

Scavini M, Shah VO, Stidley CA, Tentori F, Paine SS, Harford AM, Narva AS, Kessler DS, Bobelu A, Albert CP, Bobelu J, Jamon E, Natachu K, Neha D, Welty TK, MacCluer JW, Zager PG.

Kidney Int Suppl. 2005 Aug;(97):S126-31.

39.

Predicting 1 year mortality in an outpatient haemodialysis population: a comparison of comorbidity instruments.

Miskulin DC, Martin AA, Brown R, Fink NE, Coresh J, Powe NR, Zager PG, Meyer KB, Levey AS; Medical Directors, Dialysis Clinic, Inc.

Nephrol Dial Transplant. 2004 Feb;19(2):413-20.

PMID:
14736967
40.

Coordinated increase in albumin, fibrinogen, and muscle protein synthesis during hemodialysis: role of cytokines.

Raj DS, Dominic EA, Wolfe R, Shah VO, Bankhurst A, Zager PG, Ferrando A.

Am J Physiol Endocrinol Metab. 2004 Apr;286(4):E658-64. Epub 2004 Jan 13.

41.

Markers of inflammation, proteolysis, and apoptosis in ESRD.

Raj DS, Shah H, Shah VO, Ferrando A, Bankhurst A, Wolfe R, Zager PG.

Am J Kidney Dis. 2003 Dec;42(6):1212-20.

PMID:
14655193
42.

The Zuni kidney project: a collaborative approach to an epidemic of kidney disease.

Stidley CA, Shah VO, Scavini M, Narva AS, Kessler D, Bobelu A, MacCluer JW, Welty TK, Zager PG.

J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S139-43.

43.

Prevalence of hematuria among Zuni Indians with and without diabetes: The Zuni kidney Project.

Tentori F, Stidley CA, Scavini M, Shah VO, Narva AS, Paine S, Bobelu A, Welty TK, Maccluer JW, Zager PG.

Am J Kidney Dis. 2003 Jun;41(6):1195-204.

PMID:
12776271
44.

Epidemic of diabetic and nondiabetic renal disease among the Zuni Indians: the Zuni Kidney Project.

Shah VO, Scavini M, Stidley CA, Tentori F, Welty TK, MacCluer JW, Narva AS, Bobelu A, Albert CP, Kessler DS, Harford AM, Wong CS, Harris AA, Paine S, Zager PG.

J Am Soc Nephrol. 2003 May;14(5):1320-9.

45.

Prevalence of diabetes is higher among female than male Zuni indians.

Scavini M, Stidley CA, Shah VO, Narva AS, Tentori F, Kessler DS, Bobelu A, Albert CP, Bobelu J, Jamon E, Natachu K, Neha D, Waikaniwa M, Welty TK, MacCluer JW, Zager PG.

Diabetes Care. 2003 Jan;26(1):55-60.

PMID:
12502658
46.

The mevalonate pathway during acute tubular injury: selected determinants and consequences.

Zager RA, Shah VO, Shah HV, Zager PG, Johnson AC, Hanson S.

Am J Pathol. 2002 Aug;161(2):681-92.

47.

A population-based, cross-sectional survey of the Zuni Pueblo: a collaborative approach to an epidemic of kidney disease.

Stidley CA, Shah VO, Narva AS, Dalton D, MacCluer JW, Bobelu A, Scavini M, Welty TK, Zager PG.

Am J Kidney Dis. 2002 Feb;39(2):358-68.

PMID:
11840378
48.

Z-2 microsatellite allele is linked to increased expression of the aldose reductase gene in diabetic nephropathy.

Shah VO, Scavini M, Nikolic J, Sun Y, Vai S, Griffith JK, Dorin RI, Stidley C, Yacoub M, Vander Jagt DL, Eaton RP, Zager PG.

J Clin Endocrinol Metab. 1998 Aug;83(8):2886-91.

PMID:
9709964
49.

"U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc.

Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, Van Stone J, Levey A, Meyer KB, Klag MJ, Johnson HK, Clark E, Sadler JH, Teredesai P.

Kidney Int. 1998 Aug;54(2):561-9. Erratum in: Kidney Int 1998 Oct;54(4):1417.

50.

A commentary on 10 years of aldose reductase inhibition for limited joint mobility in diabetes.

Eaton RP, Sibbitt WL Jr, Shah VO, Dorin RI, Zager PG, Bicknell JM.

J Diabetes Complications. 1998 Jan-Feb;12(1):34-8.

PMID:
9442813

Supplemental Content

Loading ...
Support Center